These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9413685)

  • 1. In-process testing and limits.
    Sjöholm I
    Dev Biol Stand; 1997; 91():73-8. PubMed ID: 9413685
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of specifications for biotechnology products--perspective from Europe.
    Trouvin JH
    Dev Biol Stand; 1997; 91():25-30. PubMed ID: 9413679
    [No Abstract]   [Full Text] [Related]  

  • 3. Global perspective on specifications for biotechnology products--perspective from Japan.
    Hayakawa T
    Dev Biol Stand; 1997; 91():15-23. PubMed ID: 9413678
    [No Abstract]   [Full Text] [Related]  

  • 4. Specifications from a biotechnology industry perspective.
    Garnick RL
    Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raw material considerations.
    Lubiniecki AS; Shadle PJ
    Dev Biol Stand; 1997; 91():65-72. PubMed ID: 9413684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA perspective on specifications for biotechnology products--from IND to PLA.
    Murano G
    Dev Biol Stand; 1997; 91():3-13. PubMed ID: 9413677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and establishment of specifications for biopharmaceuticals.
    Davis GC; Riggin RM
    Dev Biol Stand; 1997; 91():49-54. PubMed ID: 9413683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of bioassays for the characterisation and control of biological therapeutic products produced by biotechnology.
    Thorpe R; Wadhwa M; Mire-Sluis A
    Dev Biol Stand; 1997; 91():79-88. PubMed ID: 9413686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of assay validation in specification development.
    Baffi RA
    Dev Biol Stand; 1997; 91():105-13. PubMed ID: 9413687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A united front.
    Nature; 2011 Apr; 472(7344):389-90. PubMed ID: 21525888
    [No Abstract]   [Full Text] [Related]  

  • 11. Global regulatory considerations for unified assay specifications.
    Patterson S; Lin L; Elchico J; Fuchs R; Powell S; Redhair D; Warwick M; Solli N; Méndez B
    Dev Biol Stand; 1997; 91():45-8. PubMed ID: 9413682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current practices in endotoxin and pyrogen testing in biotechnology. The Quality Assurance/Quality Control Task Group. Parenteral Drug Association.
    J Parenter Sci Technol; 1990; 44(1):39-45. PubMed ID: 2313492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council.
    Covic A; Cannata-Andia J; Cancarini G; Coppo R; Frazão JM; Goldsmith D; Ronco P; Spasovski GB; Stenvinkel P; Utas C; Wiecek A; Zoccali C; London G
    Nephrol Dial Transplant; 2008 Dec; 23(12):3731-7. PubMed ID: 18802209
    [No Abstract]   [Full Text] [Related]  

  • 14. Quality-by-design for biotechnology-related pharmaceuticals.
    Mandenius CF; Graumann K; Schultz TW; Premstaller A; Olsson IM; Petiot E; Clemens C; Welin M
    Biotechnol J; 2009 May; 4(5):600-9. PubMed ID: 19418475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid modeling for quality by design and PAT-benefits and challenges of applications in biopharmaceutical industry.
    von Stosch M; Davy S; Francois K; Galvanauskas V; Hamelink JM; Luebbert A; Mayer M; Oliveira R; O'Kennedy R; Rice P; Glassey J
    Biotechnol J; 2014 Jun; 9(6):719-26. PubMed ID: 24806479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction to papers on mycoplasmology presented at a Parenteral Drug Association mycoplasma workshop.
    Potts BJ
    Biologicals; 2010 Mar; 38(2):181-2. PubMed ID: 20079662
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioanalysis: challenges and solutions seminar.
    Roberts A
    Bioanalysis; 2011 Sep; 3(17):1905-6. PubMed ID: 21899500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quality control of biotechnology products.
    Federici MM
    Biologicals; 1994 Jun; 22(2):151-9. PubMed ID: 7917231
    [No Abstract]   [Full Text] [Related]  

  • 19. Mass spectrometry in the standardisation of recombinant products.
    Geisow MJ
    Dev Biol Stand; 1994; 83():129-33. PubMed ID: 7883085
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality control of rDNA-derived human tissue-type plasminogen activator.
    Jones AJ; Garnick RL
    Bioprocess Technol; 1990; 10():543-66. PubMed ID: 1367501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.